Kolexia
Laforgue Edouard-Jules
Psychiatrie
Hôpital Hôtel-Dieu Nantes
Nantes, France
77 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Troubles liés à une substance Troubles liés aux opiacés Maladie de Parkinson Manie Surdose Troubles sexuels d'origine physiologique Urgences Mésusage de médicament Coma

Industries

Ethypharm
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

"Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose.
Harm reduction journal   23 janvier 2024
Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database.
Journal of affective disorders   18 janvier 2024
A revisited version of the disputatio for pharmacological training: An educational study.
Therapie   18 novembre 2023
Nitrous oxide in France: Evolution of complications reported to the French monitoring system in the context of information from health authorities and regulatory measures
The International journal on drug policy   05 octobre 2023
Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data.
Epidemiology and psychiatric sciences   19 septembre 2023
Factors in the misuse of psychotropic treatments: From non-compliant prescriptions to inappropriate uses
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Experience or recommendations? The reasons of psychiatrists to choose an antipsychotic or another in schizophrenia
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
3-MMC's prohibition in the Netherlands, butterfly effect in France
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Preventing misuse of psychotropic treatment, interest of the WHO 6-step method for rationale prescribing
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
ZORRO project: An innovative method to assess the overall impact in pharmacoepidemiology
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023